Your browser doesn't support javascript.
loading
SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients.
Vetter, Marcus; Rothgiesser, Karin M; Li, Qiyu; Hawle, Hanne; Schönfeld, Wolfgang; Ribi, Karin; Riniker, Salome; von Moos, Roger; Trojan, Andreas; Kralidis, Elena; Fehr, Mathias; Müller, Andreas; Thürlimann, Beat.
Afiliación
  • Vetter M; Medical Oncology, University Hospital Basel, Basel, Switzerland.
  • Rothgiesser KM; Medical Oncology, Hematology and Immunotherapy, Cantonal Hospital Baselland, Medical University Clinic, Liestal, Switzerland.
  • Li Q; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
  • Hawle H; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
  • Schönfeld W; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
  • Ribi K; CURADIS GmbH, Erlangen, Germany.
  • Riniker S; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
  • von Moos R; IBCSG, International Breast Cancer Study Group, Bern, Switzerland.
  • Trojan A; Breast Cancer Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Kralidis E; Medical Oncology, Cantonal Hospital Chur, Chur, Switzerland.
  • Fehr M; Medical Oncology, Hirslanden Klinik Im Park, Zurich, Switzerland.
  • Müller A; Medical Oncology, Cantonal Hospital Aarau, Aarau, Switzerland.
  • Thürlimann B; Medical Oncology, Hospital Thurgau, Thurgau, Switzerland.
Endocr Oncol ; 2(1): 9-18, 2022 Jan.
Article en En | MEDLINE | ID: mdl-37435469

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Endocr Oncol Año: 2022 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Endocr Oncol Año: 2022 Tipo del documento: Article País de afiliación: Suiza